Pharmacy Services
Erectile Dysfunction Drugs and Vision Loss
July 12, 2005
There are a few post-marketing case reports of vision loss after using sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra). Patients should be advised to discontinue use and contact their physician if they experience any vision loss during therapy with sildenafil, tadalafil, or vardenafil. Patients at risk for vision loss should not receive therapy with these drugs. The product labeling for these drugs have been modified to include this information.
Additional information is available at the following links:
- MedWatch Alert, Viagra:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152735.htm - MedWatch Alert, Levitra:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm151619.htm - MedWatch Alert, Cialis:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150957.htm
Updated
July 12, 2005; University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.
Social Media
Copyright © 2013 University of Utah Health Care